The need for a low-cost, easy-to-use diagnostic platform to allow the detection infectious diseases

An Empowered Patient Podcast at Medical and Pharma Insider hosted by Karen Jagoda

Ron Chiarello PhD, Founder, CEO and Chairman of the Board of Alveo Technologies (NASDAQ: INMB) talks about the need for a low-cost, easy-to-use diagnostic platform to allow more people to detect and manage an infectious disease like COVID-19.

Winning the XPRIZE Rapid COVID-19 Testing Competition has highlighted Alveo's "be.well" diagnostic platform which uses an at-home system to take a nasal swab that gets placed in a disposable cartridge that goes into an analyzer that communicates to a mobile device with RNA-based test results in less than 30 minutes.

Listen to the podcast here (16:35) Download the transcript here

Alveo Technologies